Mrs. Erminia Scarcella is a Washington, District Of Columbia based neurologist who is specialized in Neurology. Her current practice location is 4947 Albemarle St Nw, 4910 Mass. Ave Nw #300, Washington. Patients can reach her at 202-244-5462 or can fax her at 202-244-3152. Mrs. Erminia Scarcella is MD in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1417069857. Mrs. Erminia Scarcella specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Mrs. Erminia Scarcella speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Mrs. Erminia Scarcella
Specialization:
Neurology
Gender:
Female
Credentials:
MD
Practice Address:
4947 Albemarle St Nw, 4910 Mass. Ave Nw #300, Washington, District Of Columbia, 20016-4359
Phone:
202-244-5462
Fax:
202-244-3152
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1417069857
NPI Enumeration Date:
31 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mrs. Erminia Scarcella 4947 Albemarle St Nw, 4910 Mass. Ave Nw #300 Washington, District Of Columbia
Zip:
20016
Phone Number:
202-244-5462
Fax Number:
202-244-3152
Patients can reach Mrs. Erminia Scarcella at 4947 Albemarle St Nw, 4910 Mass. Ave Nw #300, Washington, District Of Columbia or can call to book an appointment on 202-244-5462.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.